Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Peptide Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111944037B reveals advanced fragment condensation for semaglutide. Enhances purity and yield while enabling cost reduction in API manufacturing for global supply chains.
Patent CN107778351B reveals high-purity octreotide synthesis. Achieve cost reduction in peptide manufacturing with scalable all-solid-phase methods.
Patent CN104497130A reveals a novel 2+6 segment condensation method for Lanreotide, enhancing purity and yield for cost-effective peptide manufacturing supply chains.
Patent CN103214568A details a novel Fmoc solid-phase method using pseudo-proline dipeptides to enhance yield and purity for industrial secretin production.
Patent CN112194708A details a novel Procatide synthesis using FMPB-modified resin and stepwise disulfide bonding, ensuring high purity and yield for reliable supply chains.
Novel fragment condensation method for Gelpaglutide improves crude purity to over 75 percent and total yield to nearly 30 percent, offering significant cost reduction in polypeptide manufacturing.
Patent CN113667006B reveals a novel liquid-phase route for Semaglutide intermediates offering high purity and scalable manufacturing solutions for global pharmaceutical supply chains.
Patent CN105384809B reveals a segment solid-liquid method improving purity and reducing steps for Teriparatide manufacturing, offering supply chain stability.
Patent CN113748125A details a robust solid-phase method for Liraglutide and Semaglutide. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN112125970A reveals a novel solid-phase synthesis for Semaglutide using specialized Asp protection and fragment condensation to enhance yield and purity for reliable API manufacturing.
Novel liquid-phase total synthesis of Plecanatide using recyclable BDK auxiliary group offers cost reduction and high purity for API manufacturing.
Patent CN106674332B reveals a novel reverse-phase chromatography method for oxytocin, offering high purity and continuous production capabilities for pharmaceutical supply chains.
Patent CN112521482A reveals a solid-liquid combined method for nesiritide. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable routes.
Novel solid-phase synthesis method for Omega-Conotoxin GVIA. Enhances disulfide bond accuracy and yield for pharmaceutical intermediates supply chain.
Patent CN102875665A reveals a high-yield fragment condensation method for Liraglutide, offering superior purity and cost-effective manufacturing alternatives to recombinant technologies.
Patent CN103864918A reveals efficient fragment condensation for liraglutide. Enhances supply chain reliability and reduces manufacturing costs for global pharmaceutical partners.
Novel Fmoc solid-phase route for Telaprevir reduces cost and complexity. High purity API intermediate manufacturing solution for global supply chains.
Novel solid-phase synthesis of Goserelin avoids palladium reduction. Enhances purity and supply chain reliability for pharmaceutical manufacturing partners globally.
Advanced solid-phase synthesis and selective hydrogenolysis process for Buserelin and Goserelin. Reduces impurities and enhances supply chain reliability for pharmaceutical manufacturers.
Patent CN114341155B reveals optimized peptide synthesis with copper chloride chirality control. Delivers high purity opioid intermediates with reduced processing complexity for supply chains.